Skip to Content

New Drug Approvals Archive - July 2005

July 2005

July 22

Rozerem (ramelteon) Tablets

Date of Approval: July 22, 2005
Company: Takeda Pharmaceuticals North America, Inc.
Treatment for: Insomnia

Rozerem (ramelteon) is an orally active hypnotic indicated for the treatment of insomnia characterized by difficulty with sleep onset.

Rozerem (ramelteon) FDA Approval History

February 25

Aczone (dapsone)

New Formulation Approved: February 24, 2016

Aczone (dapsone) FDA Approval History

Hide